AUTOMATICA CUCINA LAVA von FONTANINI SALVATORE

Volltext bestellen

FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer von Loupakis, F, Cremolini, C, Salvatore, L, Masi, G, Sensi, E, Schirripa, M, Michelucci, A, Pfanner, E, Brunetti, I, Lupi, C, Antoniotti, C, Bergamo, F, Lonardi, S, Zagonel, V, Simi, P, Fontanini, G, Falcone, A

Volltext

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer von Loupakis, F, Ruzzo, A, Cremolini, C, Vincenzi, B, Salvatore, L, Santini, D, Masi, G, Stasi, I, Canestrari, E, Rulli, E, Floriani, I, Bencardino, K, Galluccio, N, Catalano, V, Tonini, G, Magnani, M, Fontanini, G, Basolo, F, Falcone, A, Graziano, F

Volltext

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised,... von Antoniotti, Carlotta, Rossini, Daniele, Pietrantonio, Filippo, Catteau, Aurélie, Salvatore, Lisa, Lonardi, Sara, Boquet, Isabelle, Tamberi, Stefano, Marmorino, Federica, Moretto, Roberto, Ambrosini, Margherita, Tamburini, Emiliano, Tortora, Giampaolo, Passardi, Alessandro, Bergamo, Francesca, Kassambara, Alboukadel, Sbarrato, Thomas, Morano, Federica, Ritorto, Giuliana, Borelli, Beatrice, Boccaccino, Alessandra, Conca, Veronica, Giordano, Mirella, Ugolini, Clara, Fieschi, Jacques, Papadopulos, Alexia, Massoué, Clémentine, Aprile, Giuseppe, Antonuzzo, Lorenzo, Gelsomino, Fabio, Martinelli, Erika, Pella, Nicoletta, Masi, Gianluca, Fontanini, Gabriella, Boni, Luca, Galon, Jérôme, Cremolini, Chiara

Volltext

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial von Masi, Gianluca, Dr, Loupakis, Fotios, MD, Salvatore, Lisa, MD, Fornaro, Lorenzo, MD, Cremolini, Chiara, MD, Cupini, Samanta, MD, Ciarlo, Andrea, MD, Del Monte, Francesca, PhD, Cortesi, Enrico, MD, Amoroso, Domenico, MD, Granetto, Cristina, MD, Fontanini, Gabriella, Prof, Sensi, Elisa, MD, Lupi, Cristiana, MD, Andreuccetti, Michele, CTA, Falcone, Alfredo, MD

Volltext

FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gru... von Fornaro, L., Lonardi, S., Masi, G., Loupakis, F., Bergamo, F., Salvatore, L., Cremolini, C., Schirripa, M., Vivaldi, C., Aprile, G., Zaniboni, A., Bracarda, S., Fontanini, G., Sensi, E., Lupi, C., Morvillo, M., Zagonel, V., Falcone, A.

Volltext

Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer von Schirripa, Marta, Cremolini, Chiara, Loupakis, Fotios, Morvillo, Manfredi, Bergamo, Francesca, Zoratto, Federica, Salvatore, Lisa, Antoniotti, Carlotta, Marmorino, Federica, Sensi, Elisa, Lupi, Cristiana, Fontanini, Gabriella, Gregorio, Veronica De, Giannini, Riccardo, Basolo, Fulvio, Masi, Gianluca, Falcone, Alfredo

Volltext

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer von Loupakis, Fotios, Moretto, Roberto, Aprile, Giuseppe, Muntoni, Marta, Cremolini, Chiara, Iacono, Donatella, Casagrande, Mariaelena, Ferrari, Laura, Salvatore, Lisa, Schirripa, Marta, Rossini, Daniele, De Maglio, Giovanna, Fasola, Gianpiero, Calvetti, Lorenzo, Pilotto, Sara, Carbognin, Luisa, Fontanini, Gabriella, Tortora, Giampaolo, Falcone, Alfredo, Sperduti, Isabella, Bria, Emilio

Volltext

Class 1, 2, and 3 BRAF -Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization von Schirripa, Marta, Biason, Paola, Lonardi, Sara, Pella, Nicoletta, Pino, Maria Simona, Urbano, Federica, Antoniotti, Carlotta, Cremolini, Chiara, Corallo, Salvatore, Pietrantonio, Filippo, Gelsomino, Fabio, Cascinu, Stefano, Orlandi, Armando, Munari, Giada, Malapelle, Umberto, Saggio, Serena, Fontanini, Gabriella, Rugge, Massimo, Mescoli, Claudia, Lazzi, Stefano, Reggiani Bonetti, Luca, Lanza, Giovanni, Dei Tos, Angelo Paolo, De Maglio, Giovanna, Martini, Maurizio, Bergamo, Francesca, Zagonel, Vittorina, Loupakis, Fotios, Fassan, Matteo

Volltext

Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study von Moretto, Roberto, Rossini, Daniele, Catteau, Aurélie, Antoniotti, Carlotta, Giordano, Mirella, Boccaccino, Alessandra, Ugolini, Clara, Proietti, Agnese, Conca, Veronica, Kassambara, Alboukadel, Pietrantonio, Filippo, Salvatore, Lisa, Lonardi, Sara, Tamberi, Stefano, Tamburini, Emiliano, Poma, Anello Marcello, Fieschi, Jacques, Fontanini, Gabriella, Masi, Gianluca, Galon, Jérôme, Cremolini, Chiara

Volltext

Location of Primary Tumor and Benefit From Anti‐Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild‐Type Metastatic Colorectal Cancer von Moretto, Roberto, Cremolini, Chiara, Rossini, Daniele, Pietrantonio, Filippo, Battaglin, Francesca, Mennitto, Alessia, Bergamo, Francesca, Loupakis, Fotios, Marmorino, Federica, Berenato, Rosa, Marsico, Valentina Angela, Caporale, Marta, Antoniotti, Carlotta, Masi, Gianluca, Salvatore, Lisa, Borelli, Beatrice, Fontanini, Gabriella, Lonardi, Sara, De Braud, Filippo, Falcone, Alfredo

Volltext

Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials von Moretto, Roberto, Corallo, Salvatore, Belfiore, Antonino, Rossini, Daniele, Boccaccino, Alessandra, Lonardi, Sara, Centonze, Giovanni, Morano, Federica, Germani, Marco Maria, Loupakis, Fotios, Morelli, Luca, Urbani, Lucio, Brich, Silvia, Marmorino, Federica, Prisciandaro, Michele, Aprile, Giuseppe, Fassan, Matteo, Cillo, Umberto, Cattaneo, Laura, Fontanini, Gabriella, De Braud, Filippo, Falcone, Alfredo, Milione, Massimo, Pietrantonio, Filippo, Cremolini, Chiara

Volltext

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metas... von Cremolini, Chiara, Marmorino, Federica, Bergamo, Francesca, Aprile, Giuseppe, Salvatore, Lisa, Masi, Gianluca, Dell’Aquila, Emanuela, Antoniotti, Carlotta, Murgioni, Sabina, Allegrini, Giacomo, Borelli, Beatrice, Gemma, Donatello, Casagrande, Mariaelena, Granetto, Cristina, Delfanti, Sara, Di Donato, Samantha, Schirripa, Marta, Sensi, Elisa, Tonini, Giuseppe, Lonardi, Sara, Fontanini, Gabriella, Boni, Luca, Falcone, Alfredo

Volltext

LBA20 FOLFOXIRI plus bevacizumab (bev) plus atezolizumab (atezo) versus FOLFOXIRI plus bev as first-line treatment of unresectable metastatic colorectal cancer (mCRC) patients: Res... von Cremolini, C., Rossini, D., Antoniotti, C., Pietrantonio, F., Lonardi, S., Salvatore, L., Marmorino, F., Borelli, B., Ambrosini, M., Barsotti, G., Di Stefano, B., Masi, G., Boccaccino, A., Tamberi, S., Tamburini, E., Frassineti, L.G., Simionato, F., Fontanini, G., Boni, L., Falcone, A.

Volltext

FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in mCRC: Final results of the phase II randomized MOMA trial b... von Marmorino, F., Cremolini, C., Bergamo, F., Pella, N., Antoniotti, C., Rossini, D., Dell'Aquila, E., Masi, G., Salvatore, L., Loupakis, F., Marcucci, L., Gemma, D., Cardellino, G., Borelli, B., Ricci, V., Delfanti, S., Mori, E., Tonini, G., Lonardi, S., Fontanini, G., Boni, L., Falcone, A.

Volltext

Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients von Vincenzi, Bruno, Cremolini, Chiara, Sartore-Bianchi, Andrea, Russo, Antonio, Mannavola, Francesco, Perrone, Giuseppe, Pantano, Francesco, Loupakis, Fotios, Rossini, Daniele, Ongaro, Elena, Bonazzina, Erica, Dell'Aquila, Emanuela, Imperatori, Marco, Zoccoli, Alice, Bronte, Giuseppe, De Maglio, Giovanna, Fontanini, Gabriella, Natoli, Clara, Falcone, Alfredo, Santini, Daniele, Onetti-Muda, Andrea, Siena, Salvatore, Tonini, Giuseppe, Aprile, Giuseppe

Volltext

KIF5B/RET Rearrangement in a Carcinoma of the Thyroid Gland: A Case Report of a Fatal Disease von Viola, David, Giani, Carlotta, Mazzeo, Salvatore, Ugolini, Clara, Ciampi, Raffaele, Molinaro, Eleonora, Agate, Laura, Borrelli, Nicla, Chella, Antonio, Fontanini, Gabriella, Basolo, Fulvio, Elisei, Rossella

Volltext

MS-based characterization of αs2-casein isoforms in donkey's milk von Saletti, Rosaria, Muccilli, Vera, Cunsolo, Vincenzo, Fontanini, Debora, Capocchi, Antonella, Foti, Salvatore

Volltext

Proteome analysis of Citrus sinensis L. (Osbeck) flesh at ripening time von Muccilli, Vera, Licciardello, Concetta, Fontanini, Debora, Russo, Maria Patrizia, Cunsolo, Vincenzo, Saletti, Rosaria, Reforgiato Recupero, Giuseppe, Foti, Salvatore

Volltext

CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo von Antonelli, Alessandro, Bocci, Guido, La Motta, Concettina, Ferrari, Silvia Martina, Fallahi, Poupak, Corrado, Alda, Fioravanti, Anna, Sartini, Stefania, Orlandi, Paola, Piaggi, Simona, Corti, Alessandro, Materazzi, Gabriele, Galleri, David, Ulisse, Salvatore, Fontanini, Gabriella, Danesi, Romano, Da Settimo, Federico, Miccoli, Paolo

Volltext